An NCI-designated Comprehensive Cancer Center
Camille Adeimy

Camille Adeimy, M.D.

Medical Oncologist
Clinical Expertise
  • Hematology - Oncology
Appointments
Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research
Other Languages Spoken
  • Arabic
  • French
I feel that educating our patients empowers them.
Camille Adeimy, M.D., enjoys connecting with his patients, treating them with “compassion and dedication” and serving as the “bridge between cutting-edge science and day-to-day patient care.”
 
Well-versed in all blood cancers and solid tumors, Dr. Adeimy treats patients at our Upland facility.
 
Educated in Lebanon, Dr. Adeimy received his medical degree from American University of Beirut. He continued his training in the U.S. at St. Louis University School of Medicine and Loyola University School of Medicine, Maywood, Ilinois. He also earned a master's degree in medical management at University of Southern California.
 
Dr. Adeimy has led numerous clinical trials aimed at finding better treatments for leukemia, multiple myeloma and Hodgkin’s lymphoma. He looks forward to contributing to the “exceptional cancer research” that takes place at City of Hope.
 
In addition, he has taken care of most other malignancies such as prostate, breast, and lung cancers.

Locations

1100 San Bernardino Road , Suite 1100

Upland, CA 91786

Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort. Evens AM, Kanakry JA, Sehn LH, Kritharis A, Feldman T, Kroll A, Gascoyne RD, Abramson JS, Petrich AM, Hernandez-Ilizaliturri FJ, Al-Mansour Z, Adeimy C, Hemminger J, Bartlett NL, Mato A, Caimi PF, Advani RH, Klein AK, Nabhan C, Smith SM, Fabregas JC, Lossos IS, Press OW, Fenske TS, Friedberg JW, Vose JM, Blum KA. Am J Hematol. 2015 Sep;90(9):778-83. doi: 10.1002/ajh.24082. PMID: 26044261. 

Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis. Petrich AM, Gandhi M, Jovanovic B, Castillo JJ, Rajguru S, Yang DT, Shah KA, Whyman JD, Lansigan F, Hernandez-Ilizaliturri FJ, Lee LX, Barta SK, Melinamani S, Karmali R, Adeimy C, Smith S, Dalal N, Nabhan C, Peace D, Vose J, Evens AM, Shah N, Fenske TS, Zelenetz AD, Landsburg DJ, Howlett C, Mato A, Jaglal M, Chavez JC, Tsai JP, Reddy N, Li S, Handler C, Flowers CR, Cohen JB, Blum KA, Song K, Sun HL, Press O, Cassaday R, Jaso J, Medeiros LJ, Sohani AR, Abramson JS. Blood. 2014 Oct 9;124(15):2354-61. doi: 10.1182/blood-2014-05-578963. Epub 2014 Aug 26. PMID: 25161267.

Zosteriform rash: another manifestation of "the internist's tumor". Fesler M, Adeimy C, Gonzalez J, Geary B, Chehval M, Richart J. Clin Genitourin Cancer. 2011 Sep;9(1):59-62. doi: 10.1016/j.clgc.2011.03.003. Epub 2011 May 1. No abstract available. PMID: 21729682.
In The News